Skip to content

HPV as a Possible Cause of Azoospermia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02329275
Enrollment
140
Registered
2014-12-31
Start date
2014-12-31
Completion date
2018-03-31
Last updated
2019-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV in Testis Tissue

Brief summary

Azoospermia is found in 5-20% of all men suffering from infertility, and in more than 20% azoospermia remains unexplained. The investigators suggest, that HPV may be an etiological factor in azoospermia and reduced sperm production. The investigators plan to examine the occurrence of HPV in testicular tissue from 100 azoospermic men and to compare with the HPV occurrence in testicular tissue from a control group of 40 normal, healthy men undergoing vasectomy. Since HPV, in a recent Danish study, was detected on sperm in 16% of 188 randomly selected semen donors, the investigators also plan to examine the occurrence of HPV on sperm ejaculated during the last week before vasectomy. If HPV should be found in testicular tissue from men belonging to the control group, it will be highly relevant to compare with the HPV occurrence on sperm ejaculated from the men in concern. A Linear Array HPV Genotyping Kit from Roche will be used for detection of HPV in testicular tissue and ejaculates. In total, with this test kit 37 HPV genotypes are examined for, including 13 high risk types.

Interventions

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Men with azoospermia (Group 1) and proven fertile men undergoing vasectomy (Group 2)

Exclusion criteria

* Men with testicular abnormalities (Group 2) * Men who do not understand the purpose and possible consequences of the study (both groups)

Design outcomes

Primary

MeasureTime frameDescription
HPV DNA in testicular tissueTwo yearsIn tissue from both azoospermic and proven fertile men

Secondary

MeasureTime frameDescription
HPV DNA in ejaculatesTwo yearsIn ejaculates from the proven fertile men

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026